近日,日本武田公司决定进一步致力于疫苗产品的研发,与大阪大学合作,开展一项新的3年期研究合作项目,推进含有可改善疫苗安全性和免疫应答的新型纳米粒佐剂的疫苗研究。该项目由盖茨基金会前任主管Rajeev Venkayya领衔,终极目标是使含有疏水性聚γ-谷氨酸纳米粒佐剂的疫苗产品接近商品化,其基础研究已在日本科学技术部支持下 Recently, Takeda decided to devote more efforts to the research and development of vaccine products. In cooperation with Osaka University, a new 3-year research cooperation project was launched to promote vaccine research with new nanoparticle adjuvants that can improve vaccine safety and immune response . Led by Rajeev Venkayya, former director of the Gates Foundation, the ultimate goal is to commercialize vaccine products containing hydrophobic poly-gamma-glutamic acid nanoparticle adjuvants with basic research supported by the Japan Ministry of Science and Technology